Literature DB >> 22450808

Purinergic receptors are required for HIV-1 infection of primary human macrophages.

Joy E Hazleton1, Joan W Berman, Eliseo A Eugenin.   

Abstract

Macrophages play a significant role in HIV infection, viral rebound, and the development of AIDS. However, the function of host proteins in viral replication is incompletely characterized in macrophages. Purinergic receptors P2X and P2Y are major components of the macrophage immune response to pathogens, inflammation, and cellular damage. We demonstrate that these receptors are necessary for HIV infection of primary human macrophages. Inhibition of purinergic receptors results in a significant reduction in HIV replication in macrophages. This inhibition is independent of viral strain and is dose dependent. We also identify that P2X(1), P2X(7), and P2Y(1) receptors are involved in viral replication. We show that P2X(1), but not P2X(7) or P2Y(1), is necessary for HIV entry into macrophages. We demonstrate that interaction of the HIV surface protein gp120 with macrophages stimulates an increase in ATP release. Thus, we propose that HIV's binding to macrophages triggers a local release of ATP that stimulates purinergic receptors and facilitates HIV entry and subsequent stages of viral replication. Our data implicate a novel role for a family of host proteins in HIV replication in macrophages and suggest new therapeutic targets to reduce the devastating consequences of HIV infection and AIDS.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22450808      PMCID: PMC3508684          DOI: 10.4049/jimmunol.1102482

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

Review 1.  Central nervous system damage, monocytes and macrophages, and neurological disorders in AIDS.

Authors:  Kenneth C Williams; William F Hickey
Journal:  Annu Rev Neurosci       Date:  2002-03-27       Impact factor: 12.449

2.  A sensitive and specific enzyme-based assay detecting HIV-1 virion fusion in primary T lymphocytes.

Authors:  Marielle Cavrois; Carlos De Noronha; Warner C Greene
Journal:  Nat Biotechnol       Date:  2002-09-30       Impact factor: 54.908

3.  Macrophages as a source of HIV during opportunistic infections.

Authors:  J M Orenstein; C Fox; S M Wahl
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

4.  The P2X7 receptor and Pannexin-1 are both required for the promotion of multinucleated macrophages by the inflammatory cytokine GM-CSF.

Authors:  Irma Lemaire; Simonetta Falzoni; Bin Zhang; Patrizia Pellegatti; Francesco Di Virgilio
Journal:  J Immunol       Date:  2011-08-24       Impact factor: 5.422

5.  Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages.

Authors:  D Ferrari; P Chiozzi; S Falzoni; M Dal Susino; L Melchiorri; O R Baricordi; F Di Virgilio
Journal:  J Immunol       Date:  1997-08-01       Impact factor: 5.422

6.  Multiple P2X and P2Y receptor subtypes in mouse J774, spleen and peritoneal macrophages.

Authors:  Robson Coutinho-Silva; David M Ojcius; Darek C Górecki; Pedro M Persechini; Rodrigo C Bisaggio; Anderson N Mendes; Joanne Marks; Geoffrey Burnstock; Philip M Dunn
Journal:  Biochem Pharmacol       Date:  2005-01-12       Impact factor: 5.858

7.  Activation and desensitization of the recombinant P2X1 receptor at nanomolar ATP concentrations.

Authors:  Jürgen Rettinger; Günther Schmalzing
Journal:  J Gen Physiol       Date:  2003-05       Impact factor: 4.086

8.  P2X4, P2Y1 and P2Y2 receptors on rat alveolar macrophages.

Authors:  Jonathan W Bowler; R Jayne Bailey; R Alan North; Annmarie Surprenant
Journal:  Br J Pharmacol       Date:  2003-08-26       Impact factor: 8.739

9.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury.

Authors:  Makoto Tsuda; Yukari Shigemoto-Mogami; Schuichi Koizumi; Akito Mizokoshi; Shinichi Kohsaka; Michael W Salter; Kazuhide Inoue
Journal:  Nature       Date:  2003-08-14       Impact factor: 49.962

Review 10.  Microglia in human immunodeficiency virus-associated neurodegeneration.

Authors:  Gwenn A Garden
Journal:  Glia       Date:  2002-11       Impact factor: 8.073

View more
  44 in total

Review 1.  Purinergic signaling and human immunodeficiency virus/acquired immune deficiency syndrome: From viral entry to therapy.

Authors:  Daniela F Passos; Maria Rosa C Schetinger; Daniela Br Leal
Journal:  World J Virol       Date:  2015-08-12

Review 2.  Purinergic receptors and neglected tropical diseases: why ignore purinergic signaling in the search for new molecular targets?

Authors:  P A F Pacheco; L P Dantas; L G B Ferreira; Robson Xavier Faria
Journal:  J Bioenerg Biomembr       Date:  2018-06-07       Impact factor: 2.945

3.  High-Throughput HIV-Cell Fusion Assay for Discovery of Virus Entry Inhibitors.

Authors:  Mariana Marin; Yuhong Du; Charline Giroud; Jeong Hwa Kim; Min Qui; Haian Fu; Gregory B Melikyan
Journal:  Assay Drug Dev Technol       Date:  2015-04-14       Impact factor: 1.738

Review 4.  Adenosine signaling and adenosine deaminase regulation of immune responses: impact on the immunopathogenesis of HIV infection.

Authors:  Daniela F Passos; Viviane M Bernardes; Jean L G da Silva; Maria R C Schetinger; Daniela Bitencourt Rosa Leal
Journal:  Purinergic Signal       Date:  2018-08-10       Impact factor: 3.765

5.  P2Y2 purinergic receptor modulates virus yield, calcium homeostasis, and cell motility in human cytomegalovirus-infected cells.

Authors:  Saisai Chen; Thomas Shenk; Maciej T Nogalski
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-03       Impact factor: 11.205

6.  Improved Methods to Detect Low Levels of HIV Using Antibody-Based Technologies.

Authors:  Eliseo A Eugenin; Joan W Berman
Journal:  Methods Mol Biol       Date:  2016

7.  P2X1 Receptor Antagonists Inhibit HIV-1 Fusion by Blocking Virus-Coreceptor Interactions.

Authors:  Charline Giroud; Mariana Marin; Jason Hammonds; Paul Spearman; Gregory B Melikyan
Journal:  J Virol       Date:  2015-07-01       Impact factor: 5.103

8.  Pannexin1 hemichannels are critical for HIV infection of human primary CD4+ T lymphocytes.

Authors:  J A Orellana; S Velasquez; D W Williams; J C Sáez; J W Berman; E A Eugenin
Journal:  J Leukoc Biol       Date:  2013-03-01       Impact factor: 4.962

9.  Adenosine triphosphate released from HIV-infected macrophages regulates glutamatergic tone and dendritic spine density on neurons.

Authors:  Luis B Tovar-Y-Romo; Dennis L Kolson; Veera Venkata Ratnam Bandaru; Julia L Drewes; David R Graham; Norman J Haughey
Journal:  J Neuroimmune Pharmacol       Date:  2013-05-18       Impact factor: 4.147

10.  P2X-selective purinergic antagonists are strong inhibitors of HIV-1 fusion during both cell-to-cell and cell-free infection.

Authors:  Talia H Swartz; Anthony M Esposito; Natasha D Durham; Boris M Hartmann; Benjamin K Chen
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.